These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 29181740)

  • 1. Impact of mitral valve intervention with left ventricular assist device implantation on postoperative outcomes and morphologic change.
    Hata H; Fujita T; Ishibashi-Ueda H; Kuroda K; Seguchi O; Matsumoto Y; Yanase M; Sato T; Nakajima S; Fukushima N; Kobayashi J
    J Artif Organs; 2018 Jun; 21(2):164-171. PubMed ID: 29181740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of concomitant mitral valve procedures for severe mitral regurgitation during left ventricular assist device implantation.
    Kawabori M; Kurihara C; Conyer RT; Critsinelis AC; Sugiura T; Rosengart T; Morgan JA
    J Artif Organs; 2019 Jun; 22(2):91-97. PubMed ID: 30361785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of Mitral Regurgitation With Left Ventricular Assist Device Support.
    Goodwin M; Nemeh HW; Borgi J; Paone G; Morgan JA
    Ann Thorac Surg; 2017 Sep; 104(3):811-818. PubMed ID: 28527962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular reverse remodeling with a continuous flow left ventricular assist device measured by left ventricular end-diastolic dimensions and severity of mitral regurgitation.
    Morgan JA; Brewer RJ; Nemeh HW; Murthy R; Williams CT; Lanfear DE; Tita C; Paone G
    ASAIO J; 2012; 58(6):574-7. PubMed ID: 23103696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitral valve repair for severe mitral valve regurgitation during left ventricular assist device implantation.
    Pawale A; Itagaki S; Parikh A; Pinney SP; Adams DH; Anyanwu AC
    J Thorac Cardiovasc Surg; 2019 May; 157(5):1841-1848.e1. PubMed ID: 31288361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of concomitant mitral valve repair for severe mitral regurgitation at the time of continuous-flow left ventricular assist device insertion.
    Sandoval E; Singh SK; Carillo JA; Baldwin ACW; Ono M; Anand J; Frazier OH; Mallidi HR
    Interact Cardiovasc Thorac Surg; 2017 Oct; 25(4):620-623. PubMed ID: 28962504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversibility of severe mitral valve regurgitation after left ventricular assist device implantation: single-centre observations from a real-life population of patients.
    Dobrovie M; Spampinato RA; Efimova E; da Rocha E Silva JG; Fischer J; Kuehl M; Voigt JU; Belmans A; Ciarka A; Bonamigo Thome F; Schloma V; Dmitrieva Y; Lehmann S; Hahn J; Strotdrees E; Mohr FW; Garbade J; Meyer AL
    Eur J Cardiothorac Surg; 2018 Jun; 53(6):1144-1150. PubMed ID: 29351635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Concomitant Mitral Valve Surgery With LVAD Placement: Systematic Review and Meta-Analysis.
    Choi JH; Luc JGY; Moncho Escrivá E; Phan K; Rizvi SSA; Patel S; Entwistle JW; Morris RJ; Massey HT; Tchantchaleishvili V
    Artif Organs; 2018 Dec; 42(12):1139-1147. PubMed ID: 30101551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First in human experience with an epicardial beating heart device for secondary mitral regurgitation.
    Thourani VH; George I; Rucinskas K; Kalinauskas G; Janusauskas V; Zakarkaite D; Ailawadi G; Smith R; Mack MJ
    J Thorac Cardiovasc Surg; 2021 Mar; 161(3):949-958.e4. PubMed ID: 33436291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular assist device implantation and concomitant mitral valve surgery: A systematic review and meta-analysis.
    Arjomandi Rad A; Fleet B; Zubarevich A; Nanchahal S; Naruka V; Subbiah Ponniah H; Vardanyan R; Sardari Nia P; Loubani M; Moorjani N; Schmack B; Punjabi PP; Schmitto J; Ruhparwar A; Weymann A
    Artif Organs; 2024 Jan; 48(1):16-27. PubMed ID: 37822301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right ventricular function and residual mitral regurgitation after left ventricular assist device implantation determines the incidence of right heart failure.
    Tang PC; Haft JW; Romano MA; Bitar A; Hasan R; Palardy M; Wu X; Aaronson KD; Pagani FD
    J Thorac Cardiovasc Surg; 2020 Mar; 159(3):897-905.e4. PubMed ID: 31101350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of cardiac resynchronization therapy on mitral valve apparatus geometry and clinical outcomes in patients with secondary mitral regurgitation.
    Mihos CG; Yucel E; Capoulade R; Orencole MP; Upadhyay GA; Santana O; Singh JP; Picard MH
    Echocardiography; 2017 Nov; 34(11):1561-1567. PubMed ID: 28895197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of conventional surgery versus MitraClip® therapy for moderate to severe symptomatic mitral valve regurgitation in the elderly population: an institutional experience.
    Alozie A; Paranskaya L; Westphal B; Kaminski A; Sherif M; Sindt M; Kische S; Schubert J; Diedrich D; Ince H; Steinhoff G; Öner A
    BMC Cardiovasc Disord; 2017 Mar; 17(1):85. PubMed ID: 28320316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-operative echocardiographic features associated with persistent mitral regurgitation after left ventricular assist device implantation.
    Kitada S; Kato TS; Thomas SS; Conwell SD; Russo C; Di Tullio MR; Farr M; Schulze PC; Uriel N; Jorde UP; Takayama H; Naka Y; Homma S; Mancini DM
    J Heart Lung Transplant; 2013 Sep; 32(9):897-904. PubMed ID: 23850122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting clinical outcome by indexed mitral valve tenting in functional mitral valve regurgitation.
    von Stumm M; Dudde F; Holst T; Sequeira-Gross T; Pausch J; Müller L; Sinning CR; Reichenspurner H; Girdauskas E
    Open Heart; 2021 Jan; 8(1):. PubMed ID: 33495382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of functional mitral valve regurgitation with the permanent percutaneous transvenous mitral annuloplasty system: results of the multicenter international Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients with Heart Failure trial.
    Machaalany J; Bilodeau L; Hoffmann R; Sack S; Sievert H; Kautzner J; Hehrlein C; Serruys P; Sénéchal M; Douglas P; Bertrand OF
    Am Heart J; 2013 May; 165(5):761-9. PubMed ID: 23622913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitral valve repair versus replacement in patients with ischaemic mitral regurgitation and depressed ejection fraction: risk factors for early and mid-term mortality†.
    Lio A; Miceli A; Varone E; Canarutto D; Di Stefano G; Della Pina F; Gilmanov D; Murzi M; Solinas M; Glauber M
    Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):64-9. PubMed ID: 24676552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in ischemic mitral regurgitation.
    Braun J; Bax JJ; Versteegh MI; Voigt PG; Holman ER; Klautz RJ; Boersma E; Dion RA
    Eur J Cardiothorac Surg; 2005 May; 27(5):847-53. PubMed ID: 15848325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial.
    Kanwar MK; Rajagopal K; Itoh A; Silvestry SC; Uriel N; Cleveland JC; Salerno CT; Horstmanshof D; Goldstein DJ; Naka Y; Bailey S; Gregoric ID; Chuang J; Sood P; Mehra MR
    J Heart Lung Transplant; 2020 Jun; 39(6):529-537. PubMed ID: 32279919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.